Antibodies directed against L1-CAM synergize with Genistein in inhibiting growth and survival pathways in SKOV3ip human ovarian cancer cells

Cancer Letters

Volumn 261, Issue 2, 2008, Pages 193-204

  Novak Hofer, Ilse ^a   Cohrs, Susan ^a   Grünberg, Jürgen ^a   Friedli, Alexandra ^a   Schlatter, Monika C ^b   Pfeifer, Marco ^c   Altevogt, Peter ^c   Schubiger, P August ^a  

^a ETH Zurich   (Switzerland)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Anti L1 antibody chCE7; Genistein; L1 CAM; SKOV3ip cells

Indexed keywords

GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE L1; PROTEIN KINASE B; PROTEIN TYROSINE KINASE;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; DNA PRIMERS; DRUG SYNERGISM; EPIDERMAL GROWTH FACTOR; FEMALE; GENISTEIN; HEPATOCYTE GROWTH FACTOR; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURAL CELL ADHESION MOLECULE L1; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SRC-FAMILY KINASES; TUMOR CELLS, CULTURED;

EID: 39149107444     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.11.012     Document Type: Article

References (43)

1. Lafrenie R.M., Bruckner C.A., and Bewick M.A. Cell adhesion and cancer: is there a potential for therapeutic intervention. Expert Opin. Ther. Targets 11 (2007) 727-731
2. Figarella-Branger D.F., Durbec P.L., and Rougon G.N. Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors. Cancer Res. 50 (1990) 6364-6370
3. Meli M.L., Carrel F., Waibel R., Amstutz H., Crompton N., Jaussi R., Moch H., Schubiger P.A., and Novak-Hofer I. Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells. Int. J. Cancer 83 (1999) 401-408
4. Hoefnagel C.A., Rutgers M., Buitenhuis C.K., Smets L.A., de Kraker J., Meli M., Carrel F., Amstutz H., Schubiger P.A., and Novak-Hofer I. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur. J. Nucl. Med. 28 (2001) 359-368
5. Fogel M., Gutwein P., Mechtersheimer S., Riedle S., Stoeck A., Smirnov A., Edler L., Ben-Arie A., Huszar M., and Altevogt P. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362 (2003) 869-875
6. Fogel M., Mechtersheimer S., Huszar M., Smirnov A., Abu D.A., Tilgen W., Reichrath J., Georg T., Altevogt P., and Gutwein P. L1 adhesion molecule (CD171) in development and progression of human malignant melanoma. Cancer Lett. 189 (2003) 237-247
7. Allory Y., Matsuoka Y., Bazille C., Christensen E.I., Ronco P., and Debiec H. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas. Clin. Cancer Res. 11 (2005) 1190-1197
8. Mechtersheimer S., Gutwein P., Agmon-Levin N., Stoeck A., Oleszewski M., Riedle S., Postina R., Fahrenholz F., Fogel M., Lemmon V., and Altevogt P. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J. Cell Biol. 155 (2001) 661-673
9. Primiano T., Baig M., Maliyekkel A., Chang B.D., Fellars S., Sadhu J., Axenovich S.A., Holzmayer T.A., and Roninson I.B. Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements. Cancer Cell 4 (2003) 41-53
10. Arlt M.J., Novak-Hofer I., Gast D., Gschwend V., Moldenhauer G., Grünberg J., Honer M., Schubiger P.A., Altevogt P., and Kruger A. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment. Cancer Res. 66 (2006) 936-943
11. Huszar M., Moldenhauer G., Gschwend V., Ben-Arie A., Altevogt P., and Fogel M. Expression profile analysis in multiple human tumors identifies L1 (CD171) as a molecular marker for differential diagnosis and targeted therapy. Human Pathol. 37 (2006) 1000-1008
12. Knogler K., Grünberg J., Zimmermann K., Cohrs S., Honer M., Ametamey S., Altevogt P., Schubiger P.A., and Novak-Hofer I. 67Cu-radioimmunotherapy and growth inhibition by L1-CAM antibodies in a therapy model of ovarian cancer metastasis. Clin. Cancer Res. 13 (2007) 603-611
13. Sarkar F.H., and Li Y. Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res. 66 (2006) 3347-3350
14. Hillman G.G., Forman J.D., Kucuk O., Yudelev M., Maughan R.L., Rubio J., Layer A., Tekyi-Mensah S., Abrams J., and Sarkar F.H. Genistein potentiates the radiation effect on prostate carcinoma cells. Clin. Cancer Res. 7 (2001) 382-390
15. Banerjee S., Zhang Y., Wang Z., Che M., Chiao P.J., Abbruzzese J.L., and Sarkar F.H. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int. J. Cancer 120 (2006) 906-917
16. Büchler P., Gukovskaya A.S., Mouria M., Büchler M.C., Büchler M.W., Friess H., Pandol S.J., Reber H.A., and Hines O.J. Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas 26 (2003) 264-273
17. Huang X., Chen S., Xu L., Liu Y., Deb D.K., Platanias L.C., and Bergan R.C. Genistein inhibits p38 Map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res. 65 (2005) 3470-3478
18. Singh A.V., Franke A.A., Blackburn G.L., and Zhou J. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis. Cancer Res. 66 (2006) 1851-1858
19. Sawada K., Radjabi A.R., Shinomiya N., Kistner W., Kenny H., Becker A.R., Turkyilmaz M.A., Salgia R., Yamada S.D., VandeWoude G.F., Tretiakova M.S., and Lengyel E. c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res. 67 (2007) 1670-1679
20. Corps A., Sowter H., and Smith S. Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c-Met. Int. J. Cancer 73 (1997) 151-155
21. Heiz M., Grünberg J., Schubiger P.A., and Novak-Hofer I. Hepatocyte growth factor-induced ectodomain shedding of cell adhesion molecule L1: role of the L1 cytoplasmic domain. J. Biol. Chem. 279 (2004) 31149-31156
22. Grünberg J., Knogler K., Waibel R., and Novak-Hofer I. High-yield production of recombinant antibody fragments in HEK-293 cells using sodium butyrate. Biotechniques 34 (2003) 968-972
23. Stoeck A., Gast D., Sanderson M.P., Issa Y., Gutwein P., and Altevogt P. L1-CAM in a membrane-bound or soluble form auguments protection from apoptosis in ovarian carcinoma cells. Gynecol. Oncol. 104 (2007) 461-469
24. Gutwein P., Stoeck A., Riedle S., Gast D., Runz S., Condon T.P., Marme A., Phong M.C., Linderkamp O., Skorohod A., and Altevogt P. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin. Cancer Res. 11 (2005) 2492-2501
25. Sebens-Muerkoester S., Werbing V., Sipos B., Debus M.A., Witt M., Grossmann M., Leisner D., Kötteritzsch J., Kappes H., Klöppel G., Altevogt P., Fölsch U.R., and Schäfer H. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 26 (2007) 2759-2768
26. Fan S., Wang J., Yuan R., Rockwell S., Andres J., Zlatapolskiy A., Goldberg I.D., and Rosen E.M. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene 17 (1998) 131-141
27. Fan S., Gao M., Meng Q., Laterra J.J., Symons M.H., Coniglio S., Pestell G., Goldberg I.D., and Rosen E.M. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene 24 (2005) 1749-1766
28. Silletti S., Yebra M., Perez B., Cirulli V., McMahon M., and Montgomery A.M. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J. Biol. Chem. 279 (2004) 28880-28888
29. Gavert N., Conacci-Sorrell M., Gast D., Schneider A., Altevogt P., Brabletz T., and Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J. Cell Biol. 168 (2005) 633-642
30. D. Gast, S. Riedle, Y. Issa, P. Beckhove, M.P. Sanderson, M. Arlt, G. Moldenhauer, M. Fogel, A. Krüger, P. Altevogt, The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies, Oncogene 2007, in press, doi:10.1038/sj.onc.1210747 .
31. Schaefer A.W., Kamiguchi H., Wong E.V., Beach C.M., Landreth G., and Lemmon V. Activation of MAPK signal cascade by the neural cell adhesion molecule L1 requires L1 internalization. J. Biol. Chem. 274 (1999) 37965-37973
32. Schmid R., Pruitt W.M., and Maness P.F. A MAP-kinase signaling pathway mediates neurite outgrowth on L1 and requires src-dependent endocytosis. J. Neurosci. 20 (2000) 4177-4181
33. Schaefer A.W., Kamei Y., Kamiguchi H., Wong E.V., Rapoport I., Kirchhausen T., Beach C.M., Landreth G., Lemmon S.K., and Lemmon V. L1 endocytosis is controlled by a phosphorylation-dephosphorylation cycle stimulated by outside-in signaling by L1. J. Cell Biol. 157 (2002) 1223-1232
34. Loers G., Chen S., Grumet M., and Schachner M. Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis. J. Neurochem. 92 (2005) 1463-1476
35. Bardella C., Dettori D., Olivero M., Coltella N., Mazzone M., and DiRenzo M.F. The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo. Clin. Cancer Res. 13 (2007) 2191-2198
36. Coltella N., Rasola A., Nano E., Bardella C., Dassetta M., Filigheddu N., Graziani A., Comoglio P.M., and DiRenzo M.F. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. Int. J. Cancer 118 (2006) 2981-2990
37. D. Tulasne, B. Foveau, The shadow of death on the MET tyrosine kinase receptor, Cell Death Differ. adv. online, October 5, 2007 (2007).
38. Ignelzi M.A., Miller D.R., Soriano P., and Maness P.F. Impaired neurite outgrowth of src-minus cerebellar neurons on the cell adhesion molecule L1. Neuron 12 (1994) 873-884
39. Islam R., Kristiansen L.V., Romani S., Garcia-Alonso L., and Hortsch M. Activation of EGF receptor kinase by L1-mediated homophilic cell interactions. Mol. Biol. Cell 15 (2004) 2003-2012
40. Gutwein P., Oleszewki M., Mechtersheimer S., Agmon-Levin N., and Altevogt P. Role of src kinases in the ADAM-mediated release of L1 adhesion molecule from human tumor cells. J. Biol. Chem. 275 (2000) 15490-15497
41. Nagaraj K., and Hortsch M. Phosphorylation of L1-type cell-adhesion molecules-ankyrins away. TIBS 31 (2006) 544-546
42. Thelen K., Kedar V., Panicker A.K., Schmid R.S., Midkiff B.R., and Maness P.F. The neural cell adhesion molecule L1 potentiates integrin-dependent cell migration to extracellular matrix proteins. J. Neurosci. 22 (2002) 18-31
43. Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., Altevogt P., Saftig P., and Reiss K. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell. Biol. 25 (2005) 9040-9053